🕵️ Flowco Holdings Inc. ($FLOC)
SEC insider & ownership activity, last 12 months · CIK 2035149 · every row links its SEC filing
Over the last 12 months insiders sold $361.8M with no open-market buying against it. Jonathan B. Fairbanks sold $355.1M (Mar). 1 planned sale is pending, the largest $124K (Roberts Chad). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $361.8M (26 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jonathan B. Fairbanks | 0 | – | 15 | $355.1M | Mar 26, 2026 |
| Roberts Chad | 0 | – | 11 | $6.6M | Feb 3, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Jonathan B. Fairbanks | 41.3% | 13G | May 15, 2026 | filing ↗ | |
| GEC Advisors LLC | 41.3% | 13G | May 15, 2026 | filing ↗ | |
| WD Thunder CV Ultimate GP LLC | 40.4% | 13G | May 13, 2025 | filing ↗ | |
| WD Thunder CV GP LP | 40.4% | 13G | May 13, 2025 | filing ↗ | |
| GEC Group B Ltd | 34.2% | 13G | May 15, 2026 | filing ↗ | |
| GEC Capital Group Iii-B LP | 34.2% | 13G | May 15, 2026 | filing ↗ | |
| WDE Flogistix Aggregate LLC | 28.2% | 13G | May 13, 2025 | filing ↗ | |
| GEC Estis Co-Invest II LLC | 26.4% | 13G | May 15, 2026 | filing ↗ | |
| GEC Group Ltd | 15.2% | 13G | May 15, 2026 | filing ↗ | |
| GEC Capital Group III LP | 15.2% | 13G | May 15, 2026 | filing ↗ | |
| GEC Partners III LP | 14.5% | 13G | May 15, 2026 | filing ↗ | |
| FMR LLC | 14.3% | Class A | 13G | Aug 6, 2026 | filing ↗ |
| Abigail P. Johnson | 14.3% | Class A | 13G | Aug 6, 2026 | filing ↗ |
| GEC Partners III B LP | 13.0% | 13G | May 15, 2026 | filing ↗ | |
| WD Thunder CV Parallel LP | 12.9% | 13G | May 13, 2025 | filing ↗ | |
| T. ROWE Price Associates, Inc. | 7.3% | 13G | Aug 14, 2026 | filing ↗ | |
| BlackRock, Inc. | 6.4% | Class A | 13G | Jul 28, 2026 | filing ↗ |
| American Century Investment Management, Inc. | 6.1% | 13G | Apr 7, 2026 | filing ↗ | |
| American Century Companies, Inc. | 6.1% | 13G | Apr 7, 2026 | filing ↗ | |
| Stowers Institute for Medical Research | 6.1% | 13G | Apr 7, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Roberts Chad | $103K | Sep 11, 2026 | filing ↗ |
| Roberts Chad | $26K | Sep 10, 2026 | filing ↗ |
| Roberts Chad | $211K | Sep 9, 2026 | filing ↗ |
| Roberts Chad | $199K | Sep 1, 2026 | filing ↗ |
| Roberts Chad | $46K | Aug 31, 2026 | filing ↗ |
| Roberts Chad | $124K | Aug 24, 2026 | filing ↗ |
| Roberts Chad | $1.2M | Feb 3, 2026 | filing ↗ |
| Roberts Chad | $1.0M | Jan 23, 2026 | filing ↗ |
| Roberts Chad | $291K | Jan 8, 2026 | filing ↗ |
| Roberts Chad | $2.2M | Dec 1, 2025 | filing ↗ |
| Roberts Chad | $1.8M | Nov 5, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Aug 25, 2026 | filing ↗ |
| Earnings (2.02) | Aug 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 7, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Other events (8.01) | Mar 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 2, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Other events (8.01) | Feb 3, 2026 | filing ↗ |